Search clinical trials for: RM-131

Total 2469 results

Motus Therapeutics, Inc.

Completed

Phase 2 Pilot Study to Evaluate the Safety and Efficacy of RM-131 Administered to Females With Anorexia Nervosa

Anorexia Nervosa

United States
Motus Therapeutics, Inc.

Completed

Study to Assess Pharmacodynamics of RM-131 in Patients With Diabetic Gastroparesis

Gastroparesis | Gastrointestinal Motility Disorder | Diabetes Mellitus Complications | Diabetes Mellitus Type 1 and 2

United States
Motus Therapeutics, Inc.

Completed

Phase 2 Study to Evaluate Safety and Efficacy of RM-131 Administered to Patients With Chronic Constipation

Constipation

United States
Motus Therapeutics, Inc.

Completed

Phase 2 Study to Evaluate Safety & Efficacy of RM-131 Administered to Patients With Diabetic Gastroparesis

Diabetes Mellitus | Gastroparesis | Diabetes Mellitus Complications

United States
Allergan

Completed

Safety and Efficacy of Relamorelin Administered to Participants With Vomiting Symptoms and Moderate to Severe Diabetic Gastroparesis

Diabetes Mellitus | Gastroparesis | Diabetes Mellitus Complications

United States, United Kingdom, Belgium, Israel, Germany, Poland, Sweden
Motus Therapeutics, Inc.
Mayo Clinic

Completed

Effect of Relamorelin on Satiation, Gastric Volume, Gastric Accommodation and Distal Gastric Function in Healthy Volunteers

Gastric Motility

United States
Motus Therapeutics, Inc.
Michael J. Fox Foundation for Parkinson's Research

Terminated

A Phase 2 Study to Evaluate the Safety and Efficacy of RM-131 in Patients With Parkinson's Disease & Chronic Constipation (MOVE-PD)

Parkinson's Disease

United States
Motus Therapeutics, Inc.
Mayo Clinic

Completed

Study to Evaluate the Effects of RM-131 in Patients With Chronic Constipation

Chronic Constipation

United States
Assiut University

Completed

Ultrasonographic Assessment of Lung Recruitment Maneuvers in Children Undergoing Lengthy Microsurgery Operations (RM)

Intraoperative Complications

Egypt
Purdue University

Completed

Effects of Proportioning Meat and Plant-based Protein-rich Foods on Cardiovascular Disease Risk Factors (S58)

Cardiovascular Risk Factor | Healthy Diet

United States
Rhythm Pharmaceuticals, Inc.

Recruiting

A Study of RM-718 in Healthy Subjects and in Patients With HO

Hypothalamic Obesity

United States
University Hospital, Clermont-Ferrand

Completed

Diffuse Acute Respiratory Distress Syndrome (ARDS), Recruitment Maneuver, and sRAGE (DAMAGE Study) (DAMAGE)

Acute Respiratory Distress Syndrome

France
Steven J. Hardy

Completed

Feasibility and Efficacy of a Home-based, Computerized Cognitive Training Program in Pediatric Sickle Cell Disease

Anemia, Sickle Cell

United States
Rhythm Pharmaceuticals, Inc.

Completed

Setmelanotide in a Single Patient With Partial Lipodystrophy

Obesity | Hypertriglyceridemia

United States
Rhythm Pharmaceuticals, Inc.

Active, not recruiting

Long Term Extension Trial of Setmelanotide

Obesity Associated With Defects in Leptin-melanocortin Pathway

United States, Netherlands, Canada, Germany, United Kingdom, France, Greece, Spain
Mathys Ltd Bettlach

Unknown

Clinical Study With the RM Pressfit Vitamys Cup in Combination With a Mathys Stem

Hip Replacement | Arthropathy of Hip
University Hospital, Basel, Switzerland

Recruiting

Clinical Study With the seleXys PC and the RM Pressfit Vitamys Cup

Hip Joint | Arthritis, Degenerative

Switzerland
Rhythm Pharmaceuticals, Inc.

Completed

Phase 1b/2a Study to Evaluate Safety and Efficacy of Setmelanotide in Obese Patients

Overweight and Obesity

United States
Rhythm Pharmaceuticals, Inc.

Completed

Setmelanotide for the Treatment of Leptin Receptor (LEPR) Deficiency Obesity

Leptin Receptor Deficiency Obesity

Netherlands, Germany, United Kingdom, Canada, France, Réunion
Rhythm Pharmaceuticals, Inc.

Completed

Study to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RM-493 Administered to Healthy, Obese, Non-diabetic Volunteers

Overweight | Obese
Fundación para la Investigación del Hospital Clínico...

Unknown

OLA to Lowest DP in Cardiac Surgery

Lung Collapse

Spain
Rhythm Pharmaceuticals, Inc.

Completed

Phase 2 Trial to Evaluate Safety and Efficacy of Setmelanotide (RM-493) in Obese Participants With Prader-Willi Syndrome

Prader-Willi Syndrome

United States
Rhythm Pharmaceuticals, Inc.

Completed

Setmelanotide (RM-493), Melanocortin-4 Receptor (MC4R) Agonist, in Bardet-Biedl Syndrome (BBS) and Alström Syndrome (AS) Participants With Moderate to Severe Obesity

Bardet Biedl Syndrome (BBS) | Alström Syndrome (AS)

United States, United Kingdom, France, Canada, Puerto Rico, Spain
RetMap, Inc
University of Illinois at Chicago; Illinois College of Optometry

Active, not recruiting

Evaluating a New Sensor That Measures the Health of the Retina in Normally-sighted Subjects

Electrode Site Reaction

United States
Alexandria University

Completed

Effects of Alveolar Recruitment Strategies on Arterial Oxygenation and Postoperative Inflammatory Response During Laparoscopic Bariatric Surgery: A Randomised Control Trial.

Bariatric Surgery Candidate

Egypt
David Bushnell
VA Office of Research and Development

Completed

Combination Targeted Radiotherapy in Neuroendocrine Tumors

Neuroendocrine Tumors

United States
University of Miami

Completed

Use of RM Technology in Pediatric BAI Recipients

Hearing Loss, Unilateral

United States
Aarhus University Hospital

Unknown

Paediatric Early Warning System - A Danish Multi-center Study

Paediatric Early Warning System

Denmark
BNM Clinic and Research

Completed

10 Years Evaluation of Composite Restoration

Dental Restoration, Permanent
Mansoura University

Completed

High Versus Low Positive End Expiratory Pressure With Alveolar Recruitment Maneuver in Laparoscopic Bariatric Surgeries

Anesthesia

Egypt
Mansoura University

Completed

Effects of Two Different Stepwise Lung Recruitment Maneuvers on Patient Hemodynamics During Laproscopic Surgery

Recruitment

Egypt
Rhythm Pharmaceuticals, Inc.

Completed

Setmelanotide Phase 2 Treatment Trial in Participants With Rare Genetic Disorders of Obesity

Obesity | Genetic Obesity | Obesity Due to Melanocortin 4 Receptor Deficiency

United States, United Kingdom, Germany, Netherlands, France, Canada, Greece, Israel, Spain
Charite University, Berlin, Germany

Unknown

RM-493 Treatment Trial in Proopiomelanocortin (POMC) Deficient Patients

Homozygous or Compound Heterozygous POMC, LEPR or PCSK1 Gene Mutation

Germany
G.R. Dome Medical Ltd.

Unknown

Pre-Marketing Feasibility Evaluation of the UriCap-RM - Urine Collection in Hospitalized Male Patients

Urinary Incontinence
Research Institute for Complex Problems of Cardiovascular...

Recruiting

Impact of the CareLink Express Remote Monitoring System on Early Detection of Atrial Fibrillation

Atrial Fibrillation

Russian Federation
Cambridge Glycoscience

Completed

A Study Assessing the Tolerable Upper Intake Level and Safety of Sugars From Fiber

Gastrointestinal Tolerance

Ireland
Huashan Hospital

Recruiting

A Study to Evaluate the Human Biodistribution and Dosimetry of the Radionuclide Labeled ZT-111 in Patients With Metastatic Prostate Cancer

Prostate Specific Membrane Antigen Positive Metastatic Prostate Cancer

China
Rhythm Pharmaceuticals, Inc.

Completed

Setmelanotide for the Treatment of Early-Onset Pro-Opiomelanocortin (POMC) Deficiency Obesity

Pro-opiomelanocortin (POMC) Deficiency Obesity

Belgium, United States, Canada, France, Germany, Spain, United Kingdom
University of California, San Francisco

Approved for marketing

Compassionate Use of 131I-MIBG for Patients With Malignant Pheochromocytoma

Pheochromocytoma | Paraganglioma

United States
Taipei Medical University Shuang Ho Hospital
Taipei Medical University WanFang Hospital; Tri-Service General Hospital; Asian...

Not yet recruiting

Comparison Between Robotic (RM) and Laparoscopic Myomectomy (LM)

Surgical Procedure, Unspecified | Uterine Leiomyoma

Taiwan
Rhythm Pharmaceuticals, Inc.
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

Completed

Effects of RM-493 on Energy Expenditure in Obese Individuals

Obesity | Morbid Obesity

United States
University of Miami
Cochlear

Completed

Remote Microphone (RM) - A Comparative Study

Hearing Loss, Conductive

United States
Jubilant DraxImage Inc.

Recruiting

A Study of Therapeutic Iobenguane (131-I) and Vorinostat for Recurrent or Progressive High-Risk Neuroblastoma Subjects (OPTIMUM)

Neoplasms | Neuroectodermal Tumors | Neuroblastoma

United States
Rhythm Pharmaceuticals, Inc.

Completed

Phase 2 Study to Evaluate Safety and Efficacy of RM-493 in Obese Participants

Overweight

United States
Merrimack Pharmaceuticals

Terminated

Phase 1 Combination Study of MM-151 With MM-121, MM-141, or Trametinib

Colorectal Cancer | Squamous Cell Carcinoma of the Head and Neck | Non-small Cell Lung Cancer

United States
Nottingham University Hospitals NHS Trust
National Institute for Health Research, United Kingdom

Completed

Evaluation of Cogmed Working Memory Training for Adult Hearing Aid Users (TEACH2)

Hearing Loss

United Kingdom
TransMolecular

Unknown

131-I-TM-601 Study in Adults With Recurrent High-Grade Glioma

Glioblastoma Multiforme | Malignant Glioma | Gliosarcoma | GBM | Anaplastic Astrocytoma | Oligo-Astrocytoma

United States
Cellectar Biosciences, Inc.
National Cancer Institute (NCI)

Recruiting

Novel Targeted Radiotherapy in Pediatric Patients With Inoperable Relapsed or Refractory HGG

High-Grade Glioma

United States, Canada
Fundación para la Investigación del Hospital Clínico...

Completed

Open Lung Approach Versus Standard Protective Strategies

Lung Collapse
Rhythm Pharmaceuticals, Inc.

Enrolling by invitation

A Trial of Setmelanotide in Acquired Hypothalamic Obesity

Hypothalamic Obesity

United States, Canada, United Kingdom, Germany, Netherlands

Search clinical trials for: RM-131

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Belgium

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations